Gene splicing gone wrong leads to aggressive medulloblastoma
Disturbing OTX2’s gene-splicing ability reduced tumor growth, opening possibilities for improved treatments.
Read More
Research
Baylor College of Medicine receives more than $17 million from CPRIT
The CPRIT awards support developmental research focusing on promising new insights into cancer treatment and innovative core facilities.
Read More
CoRSIVs have been found in cattle. They offer a new approach to improve the livestock industry
CoRSIVs provide information that may allow farmers to predict and select desirable cattle characteristics.
Read More
TULIPs in brain tumors could be exploited therapeutically
TULIPs are 3D genome features in PFA ependymoma that are not present in other types of pediatric brain cancer.
Read More
A neural biomarker to monitor OCD patient’s response to DBS
The findings could help demystify the process and make the therapy more accessible to a greater number of clinicians and patients.
Read More
A potential new therapeutic target for Group 3 medulloblastoma
Researchers identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma in the developing brain.
Read More
Student-mentor pair receives prestigious HHMI Gilliam Fellowship
The HHMI Gilliam fellows are recognized for their outstanding research and commitment to advancing equity and inclusion in science.
Read More
Epic tools can increase racial/ethnic diversity in clinical research
A closer look at how BPA and MyChart have been instrumental in helping connect with a diverse patient population in clinical research.
Read More
Dawn-to-dusk dry fasting could alleviate the health risks of individuals with an increased body mass index
Dawn-to-dusk dry fasting helped reduce factors associated with risk for diabetes, heart disease and other complications.
Read More
Congratulations, Dr. James R. Lupski, 2024 Mendel Lecturer and recipient of the Gilded Pea Award!
Dr. James R. Lupski has delivered more than 620 lectures in 37 countries, but none was received with nearly the same enthusiasm as his Mendel lecture this past June in Berlin.
Read More